NYSE - Delayed Quote USD

CONMED Corporation (CNMD)

70.01 -1.30 (-1.82%)
At close: April 24 at 4:00 PM EDT
68.00 -2.01 (-2.87%)
After hours: April 24 at 7:25 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,244,744.00
1,244,744.00
1,045,472.00
1,010,635.00
862,459.00
Cost of Revenue
568,499.00
568,499.00
474,227.00
442,599.00
402,159.00
Gross Profit
676,245.00
676,245.00
571,245.00
568,036.00
460,300.00
Operating Expense
555,642.00
555,642.00
501,191.00
458,319.00
414,290.00
Operating Income
120,603.00
120,603.00
70,054.00
109,717.00
46,010.00
Net Non Operating Interest Income Expense
-39,775.00
-39,775.00
-28,905.00
-35,485.00
-44,052.00
Other Income Expense
--
--
-112,011.00
-1,127.00
-355.00
Pretax Income
80,828.00
80,828.00
-70,862.00
73,105.00
1,603.00
Tax Provision
16,369.00
16,369.00
9,720.00
10,563.00
-7,914.00
Net Income Common Stockholders
64,459.00
64,459.00
-80,582.00
62,542.00
9,517.00
Diluted NI Available to Com Stockholders
64,459.00
64,459.00
-80,582.00
62,542.00
9,517.00
Basic EPS
2.10
2.10
-2.68
2.14
0.33
Diluted EPS
2.04
2.04
-2.68
1.94
0.32
Basic Average Shares
30,668.00
30,668.00
30,040.00
29,162.00
28,581.00
Diluted Average Shares
31,548.00
31,548.00
30,040.00
32,216.00
29,464.00
Total Operating Income as Reported
120,603.00
120,603.00
70,054.00
109,717.00
46,010.00
Total Expenses
1,124,141.00
1,124,141.00
975,418.00
900,918.00
816,449.00
Net Income from Continuing & Discontinued Operation
64,459.00
64,459.00
-80,582.00
62,542.00
9,517.00
Normalized Income
64,459.00
64,459.00
-80,582.00
62,542.00
9,517.00
Interest Expense
39,775.00
39,775.00
28,905.00
35,485.00
44,052.00
Net Interest Income
-39,775.00
-39,775.00
-28,905.00
-35,485.00
-44,052.00
EBIT
120,603.00
120,603.00
-41,957.00
108,590.00
45,655.00
EBITDA
192,477.00
192,477.00
27,562.00
179,333.00
118,280.00
Reconciled Cost of Revenue
568,499.00
568,499.00
474,227.00
442,599.00
402,159.00
Reconciled Depreciation
71,874.00
71,874.00
69,519.00
70,743.00
72,625.00
Net Income from Continuing Operation Net Minority Interest
64,459.00
64,459.00
-80,582.00
62,542.00
9,517.00
Normalized EBITDA
192,477.00
192,477.00
27,562.00
179,333.00
118,280.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 7/23/1987

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IART Integra LifeSciences Holdings Corporation
29.38
0.00%
 
IRTC iRhythm Technologies, Inc.
116.43
+0.08%
 
PEN Penumbra, Inc.
206.15
+0.22%
 
KIDS OrthoPediatrics Corp.
31.20
+1.86%
 
NVRO Nevro Corp.
12.51
-2.19%
 
OFIX Orthofix Medical Inc.
13.56
+2.57%
 
STE STERIS plc
202.80
-1.55%
 
ATEC Alphatec Holdings, Inc.
12.74
-1.47%
 
SNN Smith & Nephew plc
24.57
-0.93%
 
QDEL QuidelOrtho Corporation
40.82
+1.04%